Pulmonary arterial hypertension [dsyn]
Introduction [hlca]
Rare [tmco]
condition [dsyn]
Elevated [qlco]
pulmonary [bpoc]
Arterial resistance [lbtr]
Leading [tmco]
Right heart failure [dsyn]
State [geoa]
Art [ocdi]
Classification [clas]
Idiopathic Pulmonary Arterial Hypertension [dsyn]
familial [famg]
Pulmonary arterial hypertension [dsyn]
Pulmonary arterial hypertension [dsyn]
secondary [neop]
condition [dsyn]
Tissue [tisu]
Congenital heart disease [cgab, dsyn]
Hypertension, Portal [dsyn]
Human immunodeficiency virus infection [dsyn]
Appetite Suppressant [phsu]
Exposure NOS [inpo]
Echocardiography [diap]
Initial [tmco]
Investigation [hlca]
choice [inbe]
Non-Invasive Detection [hlca]
Pulmonary arterial hypertension [dsyn]
Measurement [ftcn]
pulmonary [bpoc]
Pressures [phpr]
Cardiac Output [clna]
Right heart catheterisation [diap]
Pulmonary arterial hypertension [dsyn]
Conventional Treatment [topp]
Includes [ftcn]
Non-specific [qlco]
Drugs [phsu]
Warfarin [hops, orch, phsu]
Diuretics [phsu]
Oxygen [elii, phsu]
Intravenous [spco]
Epoprostanol [bacs, eico, phsu]
First-Line Treatment [topp]
Severely [qlco]
affected patients [qlco]
Severe [qlco]
Cases [ftcn]
First-Line Treatment [topp]
bosentan [orch, phsu]
Prostacyclin [bacs, eico, phsu]
Analog [chvs]
Conclusions [idcn]
Advance [medd]
Management [ocac]
Pulmonary arterial hypertension [dsyn]
Markedly [qlco]
Improved [qlco]
Availability [ftcn]
Novel [tmco]
Specific [qlco]
Drugs [phsu]
Including [ftcn]
Type 5 [inpr]
Phosphodiesterase Inhibitors [phsu]
Novel [tmco]
Therapeutic [topp]
Exact [qlco]
treatment [ftcn]
Pulmonary arterial hypertension [dsyn]
Uncertain [idcn]
Evolution [genf]
therapy [ftcn]
Vasodilators [phsu]
Antiproliferative Agents [orch, phsu]
reflect [menp]
Advancement [ftcn]
Understanding [menp]
Mechanisms [ftcn]
Mediating [socb]
Pulmonary arterial hypertension [dsyn]
